Literature DB >> 23927031

Yellow fever revaccination guidelines change - a decision too feverish?

M P Grobusch1, A Goorhuis, R W Wieten, J D M Verberk, E F F Jonker, P J J van Genderen, L G Visser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23927031     DOI： 10.1111/1469-0691.12332

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  12 in total

Review 1.  Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection.

Authors:  J Erin Staples; Alan D T Barrett; Annelies Wilder-Smith; Joachim Hombach
Journal:  NPJ Vaccines       Date:  2020-07-06       Impact factor: 7.344

2.  Seroepidemiology of Dengue, Zika, and Yellow Fever Viruses among Children in the Democratic Republic of the Congo.

Authors:  Alexandra C Willcox; Matthew H Collins; Ramesh Jadi; Corinna Keeler; Jonathan B Parr; Dieudonné Mumba; Melchior Kashamuka; Antoinette Tshefu; Aravinda M de Silva; Steven R Meshnick
Journal:  Am J Trop Med Hyg       Date:  2018-07-05       Impact factor: 2.345

3.  Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellers.

Authors:  Nicole P Lindsey; Kalanthe A Horiuchi; Corey Fulton; Amanda J Panella; Olga I Kosoy; Jason O Velez; Elizabeth R Krow-Lucal; Marc Fischer; J Erin Staples
Journal:  J Travel Med       Date:  2018-01-01       Impact factor: 8.490

Review 4.  How advances in immunology provide insight into improving vaccine efficacy.

Authors:  Mark K Slifka; Ian Amanna
Journal:  Vaccine       Date:  2014-04-05       Impact factor: 3.641

Review 5.  Occurrence of Autoimmune Diseases Related to the Vaccine against Yellow Fever.

Authors:  Ana Cristina Vanderley Oliveira; Licia Maria Henrique da Mota; Leopoldo Luiz Dos Santos-Neto; Jozélio Freire De Carvalho; Iramaya Rodrigues Caldas; Olindo Assis Martins Filho; Pedro Luis Tauil
Journal:  Autoimmune Dis       Date:  2014-10-22

6.  Adaptive immune responses to booster vaccination against yellow fever virus are much reduced compared to those after primary vaccination.

Authors:  Michael Kongsgaard; Maria R Bassi; Michael Rasmussen; Karsten Skjødt; Søren Thybo; Mette Gabriel; Morten Bagge Hansen; Jan Pravsgaard Christensen; Allan Randrup Thomsen; Soren Buus; Anette Stryhn
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

Review 7.  Questions regarding the safety and duration of immunity following live yellow fever vaccination.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Expert Rev Vaccines       Date:  2016-06-20       Impact factor: 5.683

8.  A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination.

Authors:  Rosanne W Wieten; Emile F F Jonker; Ester M M van Leeuwen; Ester B M Remmerswaal; Ineke J M Ten Berge; Adriëtte W de Visser; Perry J J van Genderen; Abraham Goorhuis; Leo G Visser; Martin P Grobusch; Godelieve J de Bree
Journal:  PLoS One       Date:  2016-03-15       Impact factor: 3.240

Review 9.  Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection.

Authors:  J Erin Staples; Alan D T Barrett; Annelies Wilder-Smith; Joachim Hombach
Journal:  NPJ Vaccines       Date:  2020-07-06       Impact factor: 7.344

Review 10.  Yellow fever in the diagnostics laboratory.

Authors:  Cristina Domingo; Rémi N Charrel; Jonas Schmidt-Chanasit; Hervé Zeller; Chantal Reusken
Journal:  Emerg Microbes Infect       Date:  2018-07-12       Impact factor: 7.163
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.